8-K: DZS Receives Nasdaq Listing Extension, Board Member Resigns
Current Report
DZS Inc. has been granted a Nasdaq listing extension until August 5, 2024, to file restated financial statements, while also announcing the resignation of a board member.
Summary
- DZS Inc. has received an extension from the Nasdaq Hearings Panel to maintain its listing on the Nasdaq Capital Market until August 5, 2024.
- This extension is contingent upon DZS filing its restated financial statements and delinquent reports by the deadline.
- The company is working with its Audit Committee and new accounting firm, BDO USA LLP, to meet this requirement.
- David Schopp, a board member, has resigned effective May 27, 2024, to focus on other commitments.
- His resignation was not due to any disagreements with the company.
- DZS appointed two new board members, Todd Jackson and Paul Choi, in January 2024, increasing the board size to eight before Mr. Schopp's resignation.
Sentiment
Score: 4
Explanation: The sentiment is moderately negative due to the need for a listing extension and the restatement of financial statements, although the company is taking steps to address these issues. The resignation of a board member adds to the uncertainty.
Positives
- The Nasdaq listing extension provides DZS with additional time to rectify its filing deficiencies.
- The company has a well-defined plan to complete and file all restated financial statements and delinquent reports by August 5th.
- The appointment of two new board members in January 2024 demonstrates a commitment to corporate governance.
- The company has established momentum through strategic engagements with service providers in the Americas and EMEA.
Negatives
- The need for a listing extension indicates that DZS has not been compliant with Nasdaq's filing requirements.
- The resignation of a board member, even if for personal reasons, can create uncertainty.
- The company is still in the process of restating its financial statements, which can be a complex and time-consuming process.
Risks
- Failure to meet the August 5, 2024 deadline for filing restated financial statements could result in delisting from Nasdaq.
- The restatement process may uncover additional issues or require further adjustments to the financial statements.
- The company's ability to maintain its strategic engagements and growth momentum could be impacted by the ongoing financial challenges.
Future Outlook
DZS is focused on completing its restated financial statements and delinquent reports by August 5, 2024, to maintain its Nasdaq listing. The company aims to continue its strategic engagements and growth momentum.
Management Comments
- Misty Kawecki, Chief Financial Officer, stated that they are pleased with the Nasdaq extension and are working to meet the filing obligations.
- Charlie Vogt, President and CEO, thanked David Schopp for his contributions and highlighted his role in the company's growth.
- David Schopp expressed pride in the company's progress and confidence in its future success.
Industry Context
The announcement comes at a time when many companies are facing challenges in meeting regulatory filing deadlines, highlighting the importance of robust financial controls and reporting processes. The extension granted to DZS is not uncommon, but it underscores the need for companies to maintain compliance to avoid potential delisting.
Comparison to Industry Standards
- Many companies in the technology sector, particularly those experiencing rapid growth or undergoing significant changes, face challenges in maintaining timely financial reporting.
- The restatement of financial statements is not unique to DZS, and other companies such as Luckin Coffee and Valeant Pharmaceuticals have also undergone similar processes.
- The Nasdaq listing extension is a common mechanism to allow companies time to rectify compliance issues, and the August 5th deadline is a typical timeframe for such extensions.
- The appointment of a new accounting firm, BDO USA LLP, is a standard practice when a company needs to restate its financials, similar to how other companies have changed auditors during restatement processes.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Board Member | NA | Todd Jackson | January 2024 | New appointment |
| Board Member | NA | Paul Choi | January 2024 | New appointment |
| Board Member | David Schopp | NA | May 27, 2024 | Resignation |
Stakeholder Impact
- Shareholders may experience uncertainty due to the delayed financial filings and board member resignation.
- Employees may be affected by the ongoing financial challenges and the restatement process.
- Customers and suppliers may be concerned about the company's financial stability and ability to meet its obligations.
- Creditors may be monitoring the company's progress in meeting its filing requirements and financial obligations.
Next Steps
- DZS will work with BDO USA LLP to complete the restatement of its financial statements.
- The company will file all restated financial statements and delinquent reports by August 5, 2024.
- The Board will consider whether to fill the vacancy created by Mr. Schopp's resignation.
Key Dates
| Date | Description |
|---|---|
| January 2024 | DZS appointed two new board members, Todd Jackson and Paul Choi. |
| April 22, 2024 | David Schopp notified DZS of his resignation from the Board of Directors. |
| April 23, 2024 | The Nasdaq Hearings Panel granted DZS's request for continued listing. |
| April 24, 2024 | DZS issued a press release regarding the Nasdaq listing extension and board member resignation. |
| May 27, 2024 | David Schopp's resignation from the Board of Directors becomes effective. |
| August 5, 2024 | Deadline for DZS to file restated financial statements and delinquent reports to maintain Nasdaq listing. |
Keywords
Nasdaq, listing, financial statements, restatement, board of directors, resignation, compliance, DZS, BDO USA LLP, extension
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.